Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

Journal of Neuro-Oncology

Volumn 100, Issue 3, 2010, Pages 443-447

  De Braganca, Kevin C ^a   Janjigian, Yelena Y ^a   Azzoli, Christopher G ^a   Kris, Mark G ^a   Pietanza, Maria C ^a   Nolan, Craig P ^a   Omuro, Antonio M ^a   Holodny, Andrei I ^a   Lassman, Andrew B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bevacizumab; Brain metastases; Chemotherapy; Non small cell lung cancer; Radiotherapy

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; CYTARABINE; GEMCITABINE; NAVELBINE; PEMETREXED; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; BRAIN RADIATION; BRAIN SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; MALE; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SKIN ULCER; STEREOTACTIC RADIOSURGERY; TUMOR BLEEDING;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78449266761     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0200-2     Document Type: Article

References (13)

1. Cloughesy TF, Prados MD, Wen PY, Mikkelsen T, Abrey LE, Schiff D, Yung WK, Maoxia Z, Dimery I, Friedman HS (2008) A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM). J Clin Oncol 26(Suppl):Abstract 2010b, oral presentation update
2. MA Socinski CJ Langer JE Huang MM Kolb P Compton L Wang W Akerley 2009 Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases J Clin Oncol 27 5255 5261 1:CAS:528:DC%2BD1MXhsFahsLjL 10.1200/JCO.2009.22.0616 19738122
3. Akerley WL, Langer CJ, Oh Y, Strickland DK, Joo Royer S, Xia Q, Mu Y, Huang J, Socinski MA (2008) Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer [abstract]. J Clin Oncol 26: Abstract 8043
4. B Besse SF Lasserre P Compton J Huang S Augustus UP Rohr 2010 Bevacizumab safety in patients with central nervous system metastases Clin Cancer Res 16 269 278 1:CAS:528:DC%2BC3cXot1Sj 10.1158/1078-0432.CCR-09-2439 20028762
5. CP Carden JM Larkin MA Rosenthal 2008 What is the risk of intracranial bleeding during anti-VEGF therapy? Neuro Oncol 10 624 630 10.1215/15228517-2008- 010 18539884
6. SI Labidi T Bachelot I Ray-Coquard K Mosbah I Treilleux J Fayette B Favier G Galy JY Blay JP Guastalla 2009 Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series Clin Breast Cancer 9 118 121 1:CAS:528:DC%2BD1MXmtlahtbw%3D 10.3816/CBC.2009.n.021 19433393
7. A Bhaskara C Eng 2008 Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases Clin Colorectal Cancer 7 65 68 1:CAS:528:DC%2BD1cXislGis78%3D 10.3816/CCC.2008.n.010 18279580
8. MS Gordon K Margolin M Talpaz GW Sledge Jr E Holmgren R Benjamin S Stalter S Shak D Adelman 2001 Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer J Clin Oncol 19 843 850 1:CAS:528:DC%2BD3MXhtlGrt7k%3D 11157038
9. A Sandler R Gray MC Perry J Brahmer JH Schiller A Dowlati R Lilenbaum DH Johnson 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2542 2550 1:CAS:528:DC%2BD28XhtlWqsbzI 10.1056/NEJMoa061884 17167137
10. PL Nghiemphu RM Green WB Pope A Lai TF Cloughesy 2008 Safety of anticoagulation use and bevacizumab in patients with glioma Neuro Oncol 10 355 360 10.1215/15228517-2008-009 18436627
11. MJ van den Bent MA Vogelbaum PY Wen DR Macdonald SM Chang 2009 End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria J Clin Oncol 27 2905 2908 10.1200/JCO.2009.22.4998 19451418
12. DeAngelis LM, Posner JP (2009) Leptomeningeal metastases. In: DeAngelis LM, Posner JP (eds) Neurologic complications of cancer. Oxford University Press, Inc., New York, pp 240-281
13. G Srivastava V Rana S Wallace S Taylor M Debnam L Feng D Suki D Karp D Stewart Y Oh 2009 Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients J Thorac Oncol 4 333 337 10.1097/JTO.0b013e318194fad4 19190519